Table 1.
Baseline Characteristics Among Patients with and Without a History of Migraine Headaches
| Characteristic | History of Migraines n = 224 |
No History of Migraines n = 693 |
Age-Adjusted P-Value |
|---|---|---|---|
| Demographic characteristics | |||
| Age | 54 ± 11 | 59 ± 12 | <.001 |
| Postmenopausal (%) | 68 | 79 | <.001 |
| History of hysterectomy (%) | 63 | 50 | <.001 |
| History of depression (%) | 37 | 20 | <.001 |
| Income >35K (%) | 33 | 41 | .008 |
| Education ≥HS (%) | 77 | 82 | .011 |
| Non-White race (%) | 21 | 18 | .42 |
| CV risk factors | |||
| Diabetes (%) | 19 | 26 | .07 |
| Metabolic syndrome (%) | 38 | 47 | .09 |
| Family history of CAD (%) | 71 | 65 | .17 |
| Dyslipidemia (%) | 49 | 57 | .38 |
| Obese (BMI >30) (%) | 41 | 41 | .71 |
| Current smoker (%) | 24 | 19 | .79 |
| Hypertension (%) | 57 | 59 | .88 |
| Current medication use | |||
| Lipid-lowering meds (%) | 17 | 33 | <.001 |
| ATP III cardiac risk score (median, IQR) | 2.0 (1, 5) | 4.0 (1, 8) | <.001 |
| Antidepressant or other psychotropic meds (%) | 38 | 28 | .016 |
| Beta-blockers (%) | 34 | 41 | .12 |
| Aspirin (%) | 53 | 62 | .21 |
| ACE inhibitors (%) | 24 | 26 | .89 |
ACE = angiotensin-converting enzyme; ATP = adult treatment panel; BMI = body mass index; CAD = coronary artery disease; CV = cardiovascular; HS = high school; IQR = interquartile range.